|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO-B
Nominal 
168.000 -7.500 (-4.274%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 1,382,791 | 32.169% | 1,540,493 | 803,933 | 32,322 |
| Cost of Sales | (306,101) | -17.396% | (781,308) | (276,828) | (20,525) |
| Gross Profit | 1,076,690 | 59.354% | 759,185 | 527,105 | 11,797 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 409,251 | 891.475% | (467,692) | (567,364) | (889,795) | |
| Taxation | (99,025) | 36.762% | (106,442) | (48,735) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 310,226 | -- | (574,134) | (616,099) | (889,795) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 2,507 | -96.816% | 39,123 | 147,397 | 111,785 |
| Depreciation & Amortisation | 36,475 | 5.252% | 75,076 | 67,364 | 22,914 |
| Directors' Emoluments | -- | -- | 22,574 | 7,942 | 13,106 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 141.000 | -- | -284.000 | -574.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.324 | (2.836) | -- |
| NBV per share ($) | 14.401 | -- | 10.627 | -- | -- |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 310,226 |
| %Change | -- |
| EPS / (LPS) | RMB 1.410 |
| NBV Per Share (¥) | RMB 14.401 |